Who owns SAREPTA THERAPEUTICS INC NOTE 1.250 9/1?

Tip: Access positions for across all investors

Analyze quarterly positions in Sarepta Therapeutics Inc Note 1.250 9/1 with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Sarepta Therapeutics Inc Note 1.250 9/1 stock

Who bought or sold SAREPTA THERAPEUTICS INC NOTE 1.250 9/1 this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
Balyasny Asset Management 67M $59M 54% Sep 2025
 View chart
Linden Advisors 41M $36M -86% Sep 2025
 View chart
Highbridge Capital Management 37M $33M -8% Sep 2025
 View chart
Oaktree Capital Management 35M $31M 610% Sep 2025
 View chart
D. E. Shaw & Co 31M $27M 462% Sep 2025
 View chart
DG Capital Management 22M $19M 100% Sep 2025
 View chart
Calamos Advisors 15M $13M -60% Sep 2025
 View chart
Davidson Kempner Capital Management 15M $13M -81% Sep 2025
 View chart
Agf Management 14M $13M 217% Sep 2025
 View chart
Readystate Asset Management 10M $8.8M -60% Sep 2025
 View chart
LMR Partners 10M $8.8M 100% Sep 2025
 View chart
State Street Corporation 9.2M $8.1M -59% Sep 2025
 View chart
Silver Point Capital 8.0M $7.0M 100% Sep 2025
 View chart
Man Group 6.5M $5.7M 9% Sep 2025
 View chart
Capstone Investment Advisors 5.0M $4.4M -71% Sep 2025
 View chart
FMR 4.7M $4.2M -76% Sep 2025
 View chart
Bnp Paribas Investment Partners 4.4M $3.8M 0% Sep 2025
 View chart
BlackRock 4.1M $3.6M -64% Sep 2025
 View chart
Palisade Capital Management 3.3M $2.9M 0% Sep 2025
 View chart
State of Wisconsin Investment Board 3.0M $2.6M 50% Sep 2025
 View chart
Fort Baker Capital Management 2.5M $2.2M 0% Sep 2025
 View chart
Exome Asset Management 2.0M $1.8M 0% Sep 2025
 View chart
Toronto-Dominion Bank 1.1M $945k 8% Sep 2025
 View chart
Morgan Stanley 408k $294k 100% Jun 2025
 View chart
Branch Banking & Trust Company 71k $63k 0% Sep 2025
 View chart
Capital Investment Advisory Services 37k $33k 0% Sep 2025
 View chart
SG Americas Securities 15k $1.3M 0% Sep 2025
 View chart
Rothschild Investment 1.0k $880.000000 0% Sep 2025
 View chart
UBS Group 500.00 $440.000000 0% Sep 2025
 View chart

Who sold out of Sarepta Therapeutics Inc Note 1.250 9/1?

Fund or Company Name Date Sold Shares Held Valued At
Whitebox Advisors Jun 2025 56M $41M
DeepCurrents Investment Group Jun 2025 52M $38M
Tenor Capital Management Jun 2025 48M $36M
Nuveen Jun 2025 40M $29M
Leucadia National Corporation Jun 2025 23M $17M
CNH Partners Jun 2025 21M $15M
Ing Investment Management Jun 2025 18M $13M
Two Sigma Investments Jun 2025 18M $13M
Point72 Asset Management Jun 2025 17M $12M
Aristeia Capital Jun 2025 16M $12M
Millennium Management Jun 2025 10M $7.4M
Wolverine Asset Management Jun 2025 9.9M $7.3M
Wellington Management Company Jun 2025 9.9M $7.3M
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main Jun 2025 9.6M $7.1M
OZ Management Jun 2025 9.5M $7.0M
Gabelli Funds Jun 2025 8.4M $6.2M
Bnp Paribas Arbitrage, Snc Jun 2025 7.8M $5.7M
Jump Financial Jun 2025 4.0M $2.9M
Jpmorgan Chase & Co Mar 2025 3.8M $3.5M
Walleye Trading Advisors Jun 2025 2.5M $1.8M
Wells Fargo & Company Jun 2025 2.3M $1.7M
CSS Jun 2025 2.0M $1.5M
Franklin Resources Jun 2025 1.8M $1.3M
Russell Investments Jun 2025 1.8M $1.3M
Barclays Jun 2025 1.6M $1.2M
Universal- Beteiligungs- und Servicegesellschaft mbH Jun 2025 700k $519k
Teton Advisors Mar 2025 350k $326k
GAMCO Asset Management Jun 2025 300k $221k
KBC Group NV Mar 2025 200k $187k
Context Capital Management Jun 2025 43k $31M
Royal Bank of Canada Jun 2025 20k $14k
Raymond James Financial Jun 2025 5.0k $3.6k
Alpine Partners VI Jun 2025 3.5k $2.6M